When doctors use CAR T-cell therapy to fight cancer, they are essentially reprogramming your immune system. Sometimes, this powerful reset causes your body to react in unexpected ways, including attacking your own hormone glands. A recent look at safety reports from 2017 through the second quarter of 2025 found 14 specific signals pointing to these endocrine problems. The most common issue was high blood sugar, which often showed up when patients were already having a severe immune reaction. Other serious findings included adrenal insufficiency, where your body stops making enough stress hormones, and Hashimoto's thyroiditis, an autoimmune attack on the thyroid. The data also flagged a higher risk of death when these hormone issues occurred together with the severe immune reaction. These findings come from a database of safety reports, not a direct count of every patient, but the pattern is clear enough to suggest real danger.
CAR T-cell therapy may trigger rare but serious hormone problems like adrenal failure.
Photo by Navy Medicine / Unsplash
What this means for you:
Close monitoring of hormone levels is essential for patients having severe immune reactions after CAR T-cell therapy. More on Hyperglycemia
Baseline anti-GIP antibody levels associate with future diabetes-range glycemia in health checkup cohort Certain Antibodies Might Warn Of Rising Blood Sugar Levels
Frontiers · Apr 29, 2026
Admission blood glucose levels associated with NRDS severity in neonates High blood sugar linked to worse breathing in newborns with lung distress
Frontiers · Apr 23, 2026
COVID-19 pandemic associated with Hashimoto's increase and Subacute Thyroiditis decrease in Israeli retrospective cohort Thyroid Disease Rates Shifted During Pandemic
Frontiers · Apr 22, 2026
Meta-analysis of novel therapies for follicular lymphoma progression within 24 months shows high response rates. New treatments show high response rates for advanced follicular lymphoma patients
· Apr 16, 2026